This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Olivier Grenet: Innovator in Kidney Health Assessment
Introduction
Olivier Grenet is a notable inventor based in Michelbach le Haut, France. He has made significant contributions to the field of kidney health through his innovative research and patent.
Latest Patents
Olivier Grenet holds a patent titled "Use of β-2-microglobulin to assess glomerular alterations and damage in the kidney." This invention focuses on a method for measuring β-2-microglobulin to evaluate glomerular alterations or damage in the kidney. His work is crucial for advancing diagnostic techniques in nephrology.
Career Highlights
Olivier is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to contribute to important research and development initiatives in the pharmaceutical industry.
Collaborations
Olivier has collaborated with esteemed colleagues, including Daniel Robert Roth and Gerard Maurer. These partnerships have enhanced his research and broadened the impact of his innovations.
Conclusion
Olivier Grenet's work exemplifies the importance of innovation in healthcare, particularly in the assessment of kidney health. His contributions through patents and collaborations continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile